Tissue and blood biomarkers in lung cancer: a review
Lung cancer is the most common cause of cancer-related death, worldwide. Historically,
lung cancer has been divided into two main histological types: small cell and nonsmall cell …
lung cancer has been divided into two main histological types: small cell and nonsmall cell …
The economic case for precision medicine
SP Gavan, AJ Thompson, K Payne - Expert review of precision …, 2018 - Taylor & Francis
Introduction: The advancement of precision medicine into routine clinical practice has been
highlighted as an agenda for national and international health care policy. A principle barrier …
highlighted as an agenda for national and international health care policy. A principle barrier …
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC)
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost …
XM Wan, X Luo, CQ Tan, XH Zeng, YC Zhang… - Cancer, 2019 - Wiley Online Library
Background The IMpower150 trial found that adding atezolizumab to the combination of
bevacizumab and chemotherapy improved survival for patients with metastatic …
bevacizumab and chemotherapy improved survival for patients with metastatic …
Circulating HMGB1 and RAGE as clinical biomarkers in malignant and autoimmune diseases
C Pilzweger, S Holdenrieder - Diagnostics, 2015 - mdpi.com
High molecular group box 1 (HMGB1) is a highly conserved member of the HMG-box-family;
abundantly expressed in almost all human cells and released in apoptosis; necrosis or by …
abundantly expressed in almost all human cells and released in apoptosis; necrosis or by …
Facile sonochemically-assisted bioengineering of titanium dioxide nanoparticles and deciphering their potential in treating breast and lung cancers: biological …
Combining sonochemistry with phytochemistry is a modern trend in the biosynthesis of
metallic nanoparticles (NPs), which contributes to the sustainability of chemical processes …
metallic nanoparticles (NPs), which contributes to the sustainability of chemical processes …
Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
N Paracha, A Abdulla, KS MacGilchrist - Health and quality of life …, 2018 - Springer
Background Health state utility values (HSUVs) are an important input to economic
evaluations and the choice of HSUV can affect the estimate of relative cost-effectiveness …
evaluations and the choice of HSUV can affect the estimate of relative cost-effectiveness …
Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews
Background Due to extensive literature in the field of lung cancer and their heterogeneous
results, the aim of this study was to systematically review of systematic reviews studies which …
results, the aim of this study was to systematically review of systematic reviews studies which …
[HTML][HTML] Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
N Cullell, C Carrera, E Muiño, N Torres, J Krupinski… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Oral anticoagulants (OAs) are the recommended drugs to prevent cardiovascular events and
recurrence in patients with atrial fibrillation (AF) and cardioembolic stroke. We conducted a …
recurrence in patients with atrial fibrillation (AF) and cardioembolic stroke. We conducted a …
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced …
L Schluckebier, R Caetano, OU Garay, GT Montenegro… - BMC cancer, 2020 - Springer
Background The treatment of choice for advanced non–small cell lung cancer is selected
according to the presence of specific alterations. Patients should undergo molecular testing …
according to the presence of specific alterations. Patients should undergo molecular testing …